文献速递产科

剖宫产术后使用利多卡因贴片:一项随机对照试验

Lidocaine patches after cesarean sections: a randomized control trial.
PubMed 文献 · Am J Obstet Gynecol MFM · 2024-11-02

该前瞻性随机受试者盲法对照试验在单中心纳入100例剖宫产患者,按1:1随机分为安慰剂贴片组与利多卡因贴片组,93例完成数据分析。结果显示两组术后第1至4天视觉模拟评分法最大疼痛评分及平均疼痛评分均无显著差异,结论为加用利多卡因贴片未显著降低剖宫产术后疼痛评分。

要点

  • 利多卡因贴片组与安慰剂贴片组术后第1至4天视觉模拟评分法最大疼痛评分及平均疼痛评分均无显著差异。
  • 术后第1天最大疼痛评分两组比较P=.3,第2天P=.9,第3天P=.07,第4天P=.09。
  • 术后第1天平均疼痛评分两组比较P=.7,第2天P=.6,第3天P=.2,第4天P=.5。

核心结论

  • 加用利多卡因贴片未显著降低剖宫产术后视觉模拟评分法的最大或平均术后疼痛评分。
  • 作者认为需要更多关于产科术后非阿片类疼痛管理策略的研究。

研究设计与样本

  • 前瞻性随机受试者盲法对照试验,在单中心纳入剖宫产患者。
  • 排除标准包括3次及以上剖宫产、腹壁成形术、腹部疝修补术使用补片史、活跃的多物质使用、以及有阿片类药物使用障碍史且目前接受药物辅助治疗者。
  • 患者按1:1随机分配至安慰剂贴片组或利多卡因贴片组,共100例随机,93例有完整数据用于分析(安慰剂组46例,治疗组47例)。
  • 主要结局为平均视觉模拟疼痛评分(0-10分),次要结局为术后住院期间使用的总吗啡当量。
  • 研究前后进行调查以评估受试者既往镇痛使用情况(包括阿片类药物)及研究中的患者体验。

主要发现

  • 两组基线特征相似(年龄、BMI、族裔、手术时间和估计失血量)。
  • 安慰剂贴片组与利多卡因贴片组术后第1天(P=.3)、第2天(P=.9)、第3天(P=.07)、第4天(P=.09)视觉模拟评分法最大术后疼痛评分无差异。
  • 安慰剂贴片组与利多卡因贴片组术后第1天(P=.7)、第2天(P=.6)、第3天(P=.2)、第4天(P=.5)视觉模拟评分法平均术后疼痛评分无差异。
  • 研究后调查中,利多卡因贴片组0%的受访者报告其护理受到干扰,63%报告希望未来使用利多卡因贴片。

临床怎么用

  • 原文结论未据此给出临床推荐。

局限性

  • 作者指出需要更多关于产科术后非阿片类疼痛管理策略的研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Lidocaine patches are a common topical analgesic therapy but have not been thoroughly investigated in the surgical or obstetric literature. We sought to investigate the impact of adding topical lidocaine patches to routine postcesarean pain management on patients' postcesarean pain scores and opioid use. STUDY DESIGN: This is a prospective randomized subject-blinded controlled trial of patients undergoing cesarean delivery at a single institution. Individuals were excluded if they had three or more cesarean sections (CS), abdominoplasty, history of abdominal hernia repair with mesh, active polysubstance use, or history of opiate use disorder with current medication-assisted treatment. Patients were randomized via a 1:1 randomization scheme to a placebo patch or lidocaine patch. Baseline maternal characteristics were collected. The primary outcome was mean visual analog pain scores (0-10). Our secondary outcome was total morphine equivalents used over the postoperative hospital stay. Pre- and poststudy surveys were performed to evaluate subject's prior analgesia use (including opioids) and patient experience in the study. RESULTS: A total of 100 patients were randomized and 93 had complete data for analysis (46 placebo group, 47 treatment group). Groups had similar baseline characteristics (age, BMI, ethnicity, surgical time, and estimated blood loss). Mean maximum postoperative pain score by visual analog scale did not differ between placebo or lidocaine patch groups on postoperative day (POD) 1 (P=.3), day 2 (P=.9), day 3 (P=.07), or day 4 (P=.09). Mean postoperative pain score by visual analog scale did not differ between placebo or lidocaine patch groups on POD 1 (P=.7), day 2 (P=.6), day 3 (P=.2), or day 4 (P=.5). In the poststudy survey, 0% of the respondents in the lidocaine patch group reported disruption of their care and 63% reported desired use of lidocaine patch in the future. CONCLUSION: The addition of lidocaine patches did not significantly decrease the maximum or average postoperative pain scores via visual analog scale after CS. More research is needed into nonopioid pain management strategies in the postoperative period in obstetric care. El resumen está disponible en Español al final del artículo.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Arkfeld CK, Starosta A, Esencan E, et al. Lidocaine patches after cesarean sections: a randomized control trial. Am J Obstet Gynecol MFM. 2024. PMID: 39491590. doi:10.1016/j.ajogmf.2024.101536

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。